Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Arcxis Biotechnologies, a developer of systems for disease pathogen detection and clinical diagnostics, has initiated collaboration with a business area of Hoffmann-La Roche's diagnostic division, Roche Molecular Systems of Pleasanton, California.
Subscribe to our email newsletter
The effort will apply Arcxis’s proprietary technology for isolation and concentration of total RNA and genomic DNA to PCR and RT-PCR based diagnostic tests.
Arcxis believes that its rapid and sensitive methods for preparing blood and tissue will translate into significant performance benefits.
Christine Meda, president and CEO of Arcxis, said: “We are very pleased to enter into this collaboration with Roche. Partnering with a global diagnostic provider offers a unique opportunity for Arcxis to apply its technologies to the detection of infectious diseases and cancer.”